BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38438882)

  • 1. DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway.
    Xie S; Jin Y; Wang J; Li J; Peng M; Zhu X
    BMC Cancer; 2024 Mar; 24(1):296. PubMed ID: 38438882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Ma J; Chen SJ; Qin Y; Zhang YY; Sun XF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):430-437. PubMed ID: 34018361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β-catenin and Raf/ERK1/2 signaling pathways.
    Chen X; Sun Z; Zhou S; Jiang W; Li J; Song G; Zhu X
    Mol Carcinog; 2023 Aug; 62(8):1147-1162. PubMed ID: 37132991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoprotein E enhances migration of endometrial cancer cells byactivating the ERK/MMP9 signaling pathway].
    Wu C; Cheng W
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):232-241. PubMed ID: 36946043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1/MEK/ERK pathway.
    Chen Q; Hang Y; Zhang T; Tan L; Li S; Jin Y
    Am J Physiol Cell Physiol; 2018 Dec; 315(6):C863-C872. PubMed ID: 30281322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting Raf-1.
    Ye CY; Zheng CP; Ying WW; Weng SS
    Cell Cycle; 2018; 17(24):2666-2683. PubMed ID: 30382763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enoxaparin sensitizes human non-small-cell lung carcinomas to gefitinib by inhibiting DOCK1 expression, vimentin phosphorylation, and Akt activation.
    Pan Y; Li X; Duan J; Yuan L; Fan S; Fan J; Xiaokaiti Y; Yang H; Wang Y; Li X
    Mol Pharmacol; 2015; 87(3):378-90. PubMed ID: 25488183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of synuclein gamma inhibits the movability of endometrial carcinoma cells by PI3K/AKT/ERK signaling pathway.
    Ni M; Zhao Y; Wang X
    Genes Genomics; 2021 Jun; 43(6):633-641. PubMed ID: 33788083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling.
    Bao F; An S; Yang Y; Xu TR
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aumolertinib inhibits proliferation, invasion and migration and promotes apoptosis of neuroblastoma cells by downregulating MMP2 and MMP9 expression].
    Liu X; Yang Y; Cai H; Zhang Y; Fan F; Li X; Li S
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1493-1499. PubMed ID: 37814863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-24 inhibits endometrial cancer cell proliferation by promoting apoptosis through the mitochondrial intrinsic signaling pathway.
    Liao S; Yang Y; Chen S; Bi Y; Huang Q; Wei Z; Qin A; Liu B
    Biomed Pharmacother; 2020 Apr; 124():109831. PubMed ID: 31972354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-497 accelerates apoptosis while inhibiting proliferation, migration, and invasion through negative regulation of the MAPK/ERK signaling pathway via RAF-1.
    Tao L; Zhang CY; Guo L; Li X; Han NN; Zhou Q; Liu ZL
    J Cell Physiol; 2018 Oct; 233(10):6578-6588. PubMed ID: 29150931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [hsa_circ_0000231 affects the progression of tongue squamous cell carcinoma by activating Wnt/β-catenin signaling pathway].
    Chen QW; Wang DQ; Ding BX; Tang MM; Li XG; Zhou JY; Xu K; Fang ZR; Han L; Wu H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1230-1239. PubMed ID: 36319130
    [No Abstract]   [Full Text] [Related]  

  • 15. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
    Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
    Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer in vitro and in vivo via inactivating Ras/Raf/MEK/ERK signaling.
    Yang X; Zheng YT; Rong W
    Life Sci; 2019 Dec; 239():116916. PubMed ID: 31626792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway.
    Takao T; Masuda H; Kajitani T; Miki F; Miyazaki K; Yoshimasa Y; Katakura S; Tomisato S; Uchida S; Uchida H; Tanaka M; Maruyama T
    Stem Cell Res Ther; 2022 Jun; 13(1):225. PubMed ID: 35659728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin.
    Yan H; Sun BM; Zhang YY; Li YJ; Huang CX; Feng FZ; Li C
    Int J Mol Med; 2018 Nov; 42(5):2469-2480. PubMed ID: 30226564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.
    Xiong H; Chen R; Liu S; Lin Q; Chen H; Jiang Q
    J Cell Biochem; 2018 Nov; 119(10):8123-8137. PubMed ID: 29923214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of miR1290 on the growth of endometrial cancer and the related mechanism].
    Shen XC; Sun YQ; Yan L; Zhao XX
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):130-138. PubMed ID: 35184456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.